Cargando…

Lumbar Interbody Fusion Conducted on a Porcine Model with a Bioresorbable Ceramic/Biopolymer Hybrid Implant Enriched with Hyperstable Fibroblast Growth Factor 2

Many growth factors have been studied as additives accelerating lumbar fusion rates in different animal models. However, their low hydrolytic and thermal stability both in vitro and in vivo limits their workability and use. In the proposed work, a stabilized vasculogenic and prohealing fibroblast gr...

Descripción completa

Detalles Bibliográficos
Autores principales: Krticka, Milan, Planka, Ladislav, Vojtova, Lucy, Nekuda, Vladimir, Stastny, Premysl, Sedlacek, Radek, Brinek, Adam, Kavkova, Michaela, Gopfert, Eduard, Hedvicakova, Vera, Rampichova, Michala, Kren, Leos, Liskova, Kvetoslava, Ira, Daniel, Dorazilová, Jana, Suchy, Tomas, Zikmund, Tomas, Kaiser, Jozef, Stary, David, Faldyna, Martin, Trunec, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301420/
https://www.ncbi.nlm.nih.gov/pubmed/34202232
http://dx.doi.org/10.3390/biomedicines9070733
_version_ 1783726665452486656
author Krticka, Milan
Planka, Ladislav
Vojtova, Lucy
Nekuda, Vladimir
Stastny, Premysl
Sedlacek, Radek
Brinek, Adam
Kavkova, Michaela
Gopfert, Eduard
Hedvicakova, Vera
Rampichova, Michala
Kren, Leos
Liskova, Kvetoslava
Ira, Daniel
Dorazilová, Jana
Suchy, Tomas
Zikmund, Tomas
Kaiser, Jozef
Stary, David
Faldyna, Martin
Trunec, Martin
author_facet Krticka, Milan
Planka, Ladislav
Vojtova, Lucy
Nekuda, Vladimir
Stastny, Premysl
Sedlacek, Radek
Brinek, Adam
Kavkova, Michaela
Gopfert, Eduard
Hedvicakova, Vera
Rampichova, Michala
Kren, Leos
Liskova, Kvetoslava
Ira, Daniel
Dorazilová, Jana
Suchy, Tomas
Zikmund, Tomas
Kaiser, Jozef
Stary, David
Faldyna, Martin
Trunec, Martin
author_sort Krticka, Milan
collection PubMed
description Many growth factors have been studied as additives accelerating lumbar fusion rates in different animal models. However, their low hydrolytic and thermal stability both in vitro and in vivo limits their workability and use. In the proposed work, a stabilized vasculogenic and prohealing fibroblast growth factor-2 (FGF2-STAB(®)) exhibiting a functional half-life in vitro at 37 °C more than 20 days was applied for lumbar fusion in combination with a bioresorbable scaffold on porcine models. An experimental animal study was designed to investigate the intervertebral fusion efficiency and safety of a bioresorbable ceramic/biopolymer hybrid implant enriched with FGF2-STAB(®) in comparison with a tricortical bone autograft used as a gold standard. Twenty-four experimental pigs underwent L2/3 discectomy with implantation of either the tricortical iliac crest bone autograft or the bioresorbable hybrid implant (BHI) followed by lateral intervertebral fixation. The quality of spinal fusion was assessed by micro-computed tomography (micro-CT), biomechanical testing, and histological examination at both 8 and 16 weeks after the surgery. While 8 weeks after implantation, micro-CT analysis demonstrated similar fusion quality in both groups, in contrast, spines with BHI involving inorganic hydroxyapatite and tricalcium phosphate along with organic collagen, oxidized cellulose, and FGF2- STAB(®) showed a significant increase in a fusion quality in comparison to the autograft group 16 weeks post-surgery (p = 0.023). Biomechanical testing revealed significantly higher stiffness of spines treated with the bioresorbable hybrid implant group compared to the autograft group (p < 0.05). Whilst histomorphological evaluation showed significant progression of new bone formation in the BHI group besides non-union and fibrocartilage tissue formed in the autograft group. Significant osteoinductive effects of BHI based on bioceramics, collagen, oxidized cellulose, and FGF2-STAB(®) could improve outcomes in spinal fusion surgery and bone tissue regeneration.
format Online
Article
Text
id pubmed-8301420
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83014202021-07-24 Lumbar Interbody Fusion Conducted on a Porcine Model with a Bioresorbable Ceramic/Biopolymer Hybrid Implant Enriched with Hyperstable Fibroblast Growth Factor 2 Krticka, Milan Planka, Ladislav Vojtova, Lucy Nekuda, Vladimir Stastny, Premysl Sedlacek, Radek Brinek, Adam Kavkova, Michaela Gopfert, Eduard Hedvicakova, Vera Rampichova, Michala Kren, Leos Liskova, Kvetoslava Ira, Daniel Dorazilová, Jana Suchy, Tomas Zikmund, Tomas Kaiser, Jozef Stary, David Faldyna, Martin Trunec, Martin Biomedicines Article Many growth factors have been studied as additives accelerating lumbar fusion rates in different animal models. However, their low hydrolytic and thermal stability both in vitro and in vivo limits their workability and use. In the proposed work, a stabilized vasculogenic and prohealing fibroblast growth factor-2 (FGF2-STAB(®)) exhibiting a functional half-life in vitro at 37 °C more than 20 days was applied for lumbar fusion in combination with a bioresorbable scaffold on porcine models. An experimental animal study was designed to investigate the intervertebral fusion efficiency and safety of a bioresorbable ceramic/biopolymer hybrid implant enriched with FGF2-STAB(®) in comparison with a tricortical bone autograft used as a gold standard. Twenty-four experimental pigs underwent L2/3 discectomy with implantation of either the tricortical iliac crest bone autograft or the bioresorbable hybrid implant (BHI) followed by lateral intervertebral fixation. The quality of spinal fusion was assessed by micro-computed tomography (micro-CT), biomechanical testing, and histological examination at both 8 and 16 weeks after the surgery. While 8 weeks after implantation, micro-CT analysis demonstrated similar fusion quality in both groups, in contrast, spines with BHI involving inorganic hydroxyapatite and tricalcium phosphate along with organic collagen, oxidized cellulose, and FGF2- STAB(®) showed a significant increase in a fusion quality in comparison to the autograft group 16 weeks post-surgery (p = 0.023). Biomechanical testing revealed significantly higher stiffness of spines treated with the bioresorbable hybrid implant group compared to the autograft group (p < 0.05). Whilst histomorphological evaluation showed significant progression of new bone formation in the BHI group besides non-union and fibrocartilage tissue formed in the autograft group. Significant osteoinductive effects of BHI based on bioceramics, collagen, oxidized cellulose, and FGF2-STAB(®) could improve outcomes in spinal fusion surgery and bone tissue regeneration. MDPI 2021-06-25 /pmc/articles/PMC8301420/ /pubmed/34202232 http://dx.doi.org/10.3390/biomedicines9070733 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Krticka, Milan
Planka, Ladislav
Vojtova, Lucy
Nekuda, Vladimir
Stastny, Premysl
Sedlacek, Radek
Brinek, Adam
Kavkova, Michaela
Gopfert, Eduard
Hedvicakova, Vera
Rampichova, Michala
Kren, Leos
Liskova, Kvetoslava
Ira, Daniel
Dorazilová, Jana
Suchy, Tomas
Zikmund, Tomas
Kaiser, Jozef
Stary, David
Faldyna, Martin
Trunec, Martin
Lumbar Interbody Fusion Conducted on a Porcine Model with a Bioresorbable Ceramic/Biopolymer Hybrid Implant Enriched with Hyperstable Fibroblast Growth Factor 2
title Lumbar Interbody Fusion Conducted on a Porcine Model with a Bioresorbable Ceramic/Biopolymer Hybrid Implant Enriched with Hyperstable Fibroblast Growth Factor 2
title_full Lumbar Interbody Fusion Conducted on a Porcine Model with a Bioresorbable Ceramic/Biopolymer Hybrid Implant Enriched with Hyperstable Fibroblast Growth Factor 2
title_fullStr Lumbar Interbody Fusion Conducted on a Porcine Model with a Bioresorbable Ceramic/Biopolymer Hybrid Implant Enriched with Hyperstable Fibroblast Growth Factor 2
title_full_unstemmed Lumbar Interbody Fusion Conducted on a Porcine Model with a Bioresorbable Ceramic/Biopolymer Hybrid Implant Enriched with Hyperstable Fibroblast Growth Factor 2
title_short Lumbar Interbody Fusion Conducted on a Porcine Model with a Bioresorbable Ceramic/Biopolymer Hybrid Implant Enriched with Hyperstable Fibroblast Growth Factor 2
title_sort lumbar interbody fusion conducted on a porcine model with a bioresorbable ceramic/biopolymer hybrid implant enriched with hyperstable fibroblast growth factor 2
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301420/
https://www.ncbi.nlm.nih.gov/pubmed/34202232
http://dx.doi.org/10.3390/biomedicines9070733
work_keys_str_mv AT krtickamilan lumbarinterbodyfusionconductedonaporcinemodelwithabioresorbableceramicbiopolymerhybridimplantenrichedwithhyperstablefibroblastgrowthfactor2
AT plankaladislav lumbarinterbodyfusionconductedonaporcinemodelwithabioresorbableceramicbiopolymerhybridimplantenrichedwithhyperstablefibroblastgrowthfactor2
AT vojtovalucy lumbarinterbodyfusionconductedonaporcinemodelwithabioresorbableceramicbiopolymerhybridimplantenrichedwithhyperstablefibroblastgrowthfactor2
AT nekudavladimir lumbarinterbodyfusionconductedonaporcinemodelwithabioresorbableceramicbiopolymerhybridimplantenrichedwithhyperstablefibroblastgrowthfactor2
AT stastnypremysl lumbarinterbodyfusionconductedonaporcinemodelwithabioresorbableceramicbiopolymerhybridimplantenrichedwithhyperstablefibroblastgrowthfactor2
AT sedlacekradek lumbarinterbodyfusionconductedonaporcinemodelwithabioresorbableceramicbiopolymerhybridimplantenrichedwithhyperstablefibroblastgrowthfactor2
AT brinekadam lumbarinterbodyfusionconductedonaporcinemodelwithabioresorbableceramicbiopolymerhybridimplantenrichedwithhyperstablefibroblastgrowthfactor2
AT kavkovamichaela lumbarinterbodyfusionconductedonaporcinemodelwithabioresorbableceramicbiopolymerhybridimplantenrichedwithhyperstablefibroblastgrowthfactor2
AT gopferteduard lumbarinterbodyfusionconductedonaporcinemodelwithabioresorbableceramicbiopolymerhybridimplantenrichedwithhyperstablefibroblastgrowthfactor2
AT hedvicakovavera lumbarinterbodyfusionconductedonaporcinemodelwithabioresorbableceramicbiopolymerhybridimplantenrichedwithhyperstablefibroblastgrowthfactor2
AT rampichovamichala lumbarinterbodyfusionconductedonaporcinemodelwithabioresorbableceramicbiopolymerhybridimplantenrichedwithhyperstablefibroblastgrowthfactor2
AT krenleos lumbarinterbodyfusionconductedonaporcinemodelwithabioresorbableceramicbiopolymerhybridimplantenrichedwithhyperstablefibroblastgrowthfactor2
AT liskovakvetoslava lumbarinterbodyfusionconductedonaporcinemodelwithabioresorbableceramicbiopolymerhybridimplantenrichedwithhyperstablefibroblastgrowthfactor2
AT iradaniel lumbarinterbodyfusionconductedonaporcinemodelwithabioresorbableceramicbiopolymerhybridimplantenrichedwithhyperstablefibroblastgrowthfactor2
AT dorazilovajana lumbarinterbodyfusionconductedonaporcinemodelwithabioresorbableceramicbiopolymerhybridimplantenrichedwithhyperstablefibroblastgrowthfactor2
AT suchytomas lumbarinterbodyfusionconductedonaporcinemodelwithabioresorbableceramicbiopolymerhybridimplantenrichedwithhyperstablefibroblastgrowthfactor2
AT zikmundtomas lumbarinterbodyfusionconductedonaporcinemodelwithabioresorbableceramicbiopolymerhybridimplantenrichedwithhyperstablefibroblastgrowthfactor2
AT kaiserjozef lumbarinterbodyfusionconductedonaporcinemodelwithabioresorbableceramicbiopolymerhybridimplantenrichedwithhyperstablefibroblastgrowthfactor2
AT starydavid lumbarinterbodyfusionconductedonaporcinemodelwithabioresorbableceramicbiopolymerhybridimplantenrichedwithhyperstablefibroblastgrowthfactor2
AT faldynamartin lumbarinterbodyfusionconductedonaporcinemodelwithabioresorbableceramicbiopolymerhybridimplantenrichedwithhyperstablefibroblastgrowthfactor2
AT trunecmartin lumbarinterbodyfusionconductedonaporcinemodelwithabioresorbableceramicbiopolymerhybridimplantenrichedwithhyperstablefibroblastgrowthfactor2